The Effects of NSAIDs on Bone Metabolism Following Exercise
NCT05512013 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 12
Last updated 2023-11-29
Summary
The purpose of this study is to determine the effects of a single dose of non-steroidal anti-inflammatory drugs on post-exercise markers of bone and muscle metabolism.
Conditions
- Bone Resorption
- Stress Fracture
- Bone Injury
Interventions
- DRUG
-
Ibuprofen 800 mg
Ibuprofen taken orally 2 hours prior to exercise
- DRUG
-
Celecoxib 200mg
Celebrex taken orally 2 hours prior to exercise
- DRUG
-
Flurbiprofen 100 mg
Flurbiprofen taken orally 2 hours prior to exercise
- DRUG
-
Inert placebo taken orally 2 hours prior to exercise
Sponsors & Collaborators
-
United States Army Research Institute of Environmental Medicine
lead FED
Study Design
- Allocation
- RANDOMIZED
- Purpose
- BASIC_SCIENCE
- Masking
- TRIPLE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Max Age
- 42 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2022-02-15
- Primary Completion
- 2023-04-01
- Completion
- 2023-04-01
- FDA Drug
- Yes
Countries
- United States
Study Locations
More Related Trials
-
Effects of Dual Cyclooxygenase-2 and Carbonic Anhydrase Inhibition
NCT00780325 ·Status: TERMINATED ·Phase: PHASE1
-
Variability in Response to Non-steroidal Anti-inflammatory Drugs
NCT02502006 ·Status: TERMINATED ·Phase: PHASE1
-
Effect of Selective and Nonselective Cyclooxygenase Enzyme Inhibition on Arterial Blood Pressure and Cerebral Blood Flow With Exposure to Intermittent Hypoxia in Humans
NCT01280006 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Effectiveness of Theramine on Chronic Back Pain
NCT01468025 ·Status: COMPLETED ·Phase: PHASE3
-
Celebrex Low Dose ASA Study Examining the Incidence of Gastroduodenal Ulcers in a Healthy Population
NCT00137033 ·Status: COMPLETED ·Phase: PHASE4
-
Lipidomics Screening of Celecoxib in ex Vivo Human Whole Blood Assay - Part B
NCT02413203 ·Status: COMPLETED ·Phase: NA
-
PF-06372865 In Subjects With Chronic Low Back Pain
NCT02262754 ·Status: COMPLETED ·Phase: PHASE2
-
Pharmacokinetics Study Comparing Topical Diclofenac/Menthol Gels With Voltaren Gel and Oral Diclofenac Sodium
NCT02201238 ·Status: COMPLETED ·Phase: PHASE1
-
The Use of Methylsulfonylmethane (MSM) in the Treatment of Low Back Pain
NCT02268305 ·Status: COMPLETED ·Phase: PHASE3
-
RN624 In Adult Patients With Chronic Low Back Pain
NCT00584870 ·Status: COMPLETED ·Phase: PHASE2
-
The Effect of Naproxen on the Pharmacokinetic Profile of LC350189 in Healthy Adults
NCT04139824 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Evaluate Pharmacokinetic Drug Interactions and Safety of Naproxen, Aceclofenac, Celecoxib and Ilaprazole
NCT05237297 ·Status: COMPLETED ·Phase: PHASE1
-
A Six Week Study Of The Pain Relieving Effects Of Celecoxib 200 Mg Twice Daily Compared To Tramadol 50 Mg Four Times Daily In Patients With Chronic Low Back Pain
NCT00662558 ·Status: COMPLETED ·Phase: PHASE3
-
Phase I Study PK Study With OXP005 and Naprosyn
NCT02351024 ·Status: COMPLETED ·Phase: PHASE1
-
Effect of Food on the Pharmacokinetics of Meloxicam in Healthy Volunteers
NCT02181309 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Assess the Safety and Tolerability, Including Gastrointestinal Safety, Pharmacokinetics and Pharmacodynamics of ASP7657 in Caucasian Healthy Male and Female Subjects
NCT02108548 ·Status: TERMINATED ·Phase: PHASE1
-
A Clinical Trial to Compare Safety and Effectiveness for Relieving Tenderness of 10% Naproxen Gel vs. a 2.32% Diclofenac Diethylamine Gel in the Treatment of Strains and Bruises of the Legs.
NCT05026320 ·Status: COMPLETED ·Phase: PHASE2
-
Celebrex for Pain Relief After Oral Surgery
NCT00006299 ·Status: COMPLETED ·Phase: PHASE2
-
The Effect of a Non-hormonal Cox-2 Inhibitor (Celebrex) on Ovulation
NCT01129245 ·Status: COMPLETED ·Phase: NA
-
Changes in mRNA Expression Following Exposure to Naproxen
NCT01090596 ·Status: COMPLETED ·Phase: NA
-
Endobiotics for Phenotyping of Human Cytochrome P450 Enzymes
NCT04188028 ·Status: COMPLETED ·Phase: NA
-
A Comparative Bioavailability and Pharmacokinetic Study of TNX-102 2.4 mg and Cyclobenzaprine 5 mg Tablets in Healthy Adults.
NCT01490788 ·Status: COMPLETED ·Phase: PHASE1
-
Actual Use Trial of Naproxen Sodium
NCT01427803 ·Status: COMPLETED ·Phase: PHASE3
-
Celecoxib (Celebrex) in the Management of Acute Renal Colic
NCT00304317 ·Status: WITHDRAWN ·Phase: PHASE4
-
Alzheimer's Disease Anti-Inflammatory Prevention Trial (ADAPT)
NCT00007189 ·Status: COMPLETED ·Phase: PHASE3